Overview

Location [1]
6q22.31
Protein [2]
Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2
Synonyms [1]
TCBA1, NKAIP2, TCBA, FAM77B

NKAIN2 is altered in 0.09% of all cancers with breast invasive ductal carcinoma, invasive breast carcinoma, lung adenocarcinoma, appendix adenocarcinoma, and colon adenocarcinoma having the greatest prevalence of alterations [3].

NKAIN2 GENIE Cases - Top Diseases

The most common alteration in NKAIN2 is NKAIN2-ROS1 Fusion (0.02%) [3].

NKAIN2 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.